Investing.com - Artelo Biosciences reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Artelo Biosciences announced earnings per share of $-0.8200 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.9133 on revenue of $0.00.
Artelo Biosciences 's are down 41.36% and is trading at $2.8400 , still down 82.79% from its 52 week high of $16.50 set on Monday, November 8, 2021.
Artelo Biosciences shares gained 3.65% to trade at $2.8400 in intra-day trade the report.
Artelo Biosciences follows other major Healthcare sector earnings this month
Artelo Biosciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar